Slone Partners Places Warren Cresswell as Chief Executive Officer at Perspectum

New CEO brings more than 25 years of experience across diagnostics, medical devices, and precision healthcare

SOUTH RIDING, Va., Oct. 6, 2026 /PRNewswire/ -- Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, today announced the placement of Warren Cresswell as Chief Executive Officer (CEO) at Perspectum, an Oxford, England-based precision health company that delivers non-invasive solutions to accelerate drug development and improve patient outcomes in liver and cardiometabolic disease.

Warren Cresswell is a global life sciences executive with more than 25 years of experience across diagnostics, pharmaceuticals, medical devices, and laboratory services. He was previously President and CEO of Prometheus Laboratories, a Nestlé Health Science company, where he led the diagnostics business through a period of significant growth. He has built commercial and CLIA-certified laboratory infrastructure for FDA-cleared diagnostics in the United States, and most recently, while serving as CEO, he has led a precision oncology company.

"Warren brings an exceptional combination of global leadership experience, commercial expertise, and deep knowledge across diagnostics and precision health," said Leslie Loveless, CEO and Managing Partner at Slone Partners. "His proven ability to build and scale organizations will be tremendously valuable as Perspectum advances its innovative technologies and expands its impact on drug development and patient care. We are delighted to have helped bring Warren and the Perspectum team together."

"Warren's breadth of experience made him an outstanding fit for Perspectum at this important stage of the company's evolution," said Sona Stroud, Senior Partner at Slone Partners, who led the search. "He brings a unique combination of scientific and technology expertise with the commercial and operational leadership needed to translate innovation into meaningful clinical and business impact. It was a genuine pleasure working with Perspectum's highly accomplished and thoughtful board and with Warren, who is an exceptional leader and person. Bringing the two together made this search particularly rewarding, and I am incredibly excited to see what they accomplish."

"I am thrilled with the selection by the Board's search committee of Warren Cresswell to serve as Perspectum's next CEO. Warren has the leadership talent and experience that are the right match for Perspectum at this time in its growth and development. We are most enthusiastic to have him at the helm," said Dr. Michael Rosenblatt, Chairperson, Perspectum.

Warren holds a BA in Chemistry from California State University and an MBA from the University of Pittsburgh.

ABOUT SLONE PARTNERS
With a dedicated focus on the life sciences and healthcare industries, Slone Partners is a premier executive search and talent advisory firm with more than 25 years of success delivering visionary leaders and fractional talent who build and scale amazing organizations. With a nationwide presence and global reach, we specialize in discovering and placing innovative leaders, including world-class Board, C-Suite, and upper management professionals. To learn more about Slone Partners' value proposition and our many success stories, visit https://www.slonepartners.com or call 888.784.3422.

ABOUT PERSPECTUM
Perspectum is a global medical technology company developing advanced imaging solutions that support earlier diagnosis and more personalised care for patients with cardiometabolic conditions. Operating across the UK, EU, Asia, and USA, Perspectum combines biomedical science, clinical expertise and quantitative imaging analytics to help clinicians detect disease sooner and make more informed decisions about patient care. For additional information, please visit perspectum.com.

SOURCE Slone Partners